{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"CEO Podcast | The leaders shaping our world","title":"Mochi Founder & CEO Dr. Myra Ahmad - How GLP-1s Are Transforming Healthcare","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/22145480\"></iframe>","width":"100%","height":180,"duration":1301,"description":"Dr. Myra Ahmad, Founder & CEO of Mochi, joins Clint Betts for a conversation on obesity medicine, GLP-1 medications, telehealth, healthcare innovation, and the future of personalized metabolic care.\nMochi is building a marketplace for evidence-based healthcare, helping patients connect with providers for customized treatment plans focused on obesity, metabolic health, menopause care, skincare, and more. In this episode, Dr. Ahmad explains why GLP-1 medications like Ozempic and Wegovy are fundamentally changing healthcare — and why obesity should be treated like any other chronic medical condition.\nThe conversation also explores telemedicine, personalized medicine, healthcare costs, startup culture, compounding pharmacies, and the growing role of technology in healthcare delivery.\n00:00:00 - Introduction and Welcome\n00:00:13 - What is Mochi?\n00:00:31 - Revolution in Metabolic Health\n00:01:01 - Mochi's Unique Approach\n00:01:48 - Future of Healthcare\n00:02:11 - Dr. Ahmad's Background and Inspiration\n00:02:33 - The Obesity Epidemic\n00:03:37 - Factors Contributing to Obesity\n00:04:12 - Socioeconomic Factors in Obesity\n00:05:02 - Government and Food Industry's Role\n00:05:24 - Decline in Obesity Rates\n00:05:55 - Anti-GLP-1 Sentiment\n00:06:19 - Medication Management and Supervision\n00:07:29 - Personalized Medication and Compounding\n00:08:28 - Understanding Compounded GLP-1s\n00:09:47 - Future of Personalized Medication\n00:10:17 - Why Drugs are Expensive\n00:11:27 - A Day in the Life of a CEO\n00:12:05 - Funding and Profitability\n00:12:24 - Competitive Landscape\n00:13:18 - Building the Team and Culture\n00:13:37 - Advantages of Starting in San Francisco\n00:14:03 - Startup Culture in San Francisco\n00:14:55 - Reading Recommendations for CEOs\n00:15:29 - Regulatory Hurdles in Health Tech\n00:16:40 - Transition from Medicine to Startup\n00:17:42 - Impact of Being an MD\n00:18:29 - Macroeconomic Environment\n00:19:45 - Political Impact on Healthcare\n00:20:49 - Final Question: Who Gave...","thumbnail_url":"https://img.transistorcdn.com/1dy8XILYZ5TplRivmnv0DoX_g7XXqFV5bS1REcb0pIM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xZDc3/ODAyODNkMmRmMDc5/MDQ3NWI5ZWEzZWFk/NTJhMS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}